Who owns the PATHOGENDX trademark?

The PATHOGENDX trademark is owned by PathogenDx, Inc.

What class is the PATHOGENDX trademark registered in?

The PATHOGENDX trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for PATHOGENDX?

The USPTO serial number for PATHOGENDX is 88574483.

What is the registration number for PATHOGENDX?

PATHOGENDX is registered under USPTO registration number 6253190.

Sealvo

Home Search: PATHOGENDXPATHOGENDX #88574483

Back

Updated Oct 26, 2026·12 searches this week

View on USPTO TSDR Find similar marks

PAT

USPTO Trademark Record

REGISTERED

PATHOGENDX

SN 88574483·Reg 6253190·Filed Aug 11, 2019

Owner PathogenDx, Inc

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

PATHOGENDX (Serial No. 88574483), Registration No. 6253190, is a registered US trademark filed on Aug 11, 2019 by PathogenDx, Inc. This trademark covers Class 042 (Scientific, technology & SaaS services).

Renewal window: January 19, 202784 days remaining

Mark Intelligence

PATHOGENDX (Reg. #6253190) is a registered US trademark that has been protecting its owner, PathogenDx, Inc, since 2019. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research....

FILED

Aug 11, 2019

SERIAL

88574483

REG#

6253190

REGISTERED

Jan 19, 2021

Filing Information

StatusREGISTERED

Filing DateAug 11, 2019

Serial Number88574483

Registration No.6253190

Registration DateJan 19, 2021

Status DateJan 19, 2021

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Dec 31, 2019

First use in commerce: Dec 31, 2019

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

28 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jan 19, 2026

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-SUPPLEMENTAL REGISTER

Jan 19, 2021

REGISTERED-SUPPLEMENTAL REGISTER

LAW OFFICE PUBLICATION REVIEW COMPLETED

Dec 16, 2020

LAW OFFICE PUBLICATION REVIEW COMPLETED

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Dec 03, 2020

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

USE AMENDMENT ACCEPTED

Dec 02, 2020

USE AMENDMENT ACCEPTED

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Dec 02, 2020

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

AMENDMENT TO USE PROCESSING COMPLETE

Dec 01, 2020

AMENDMENT TO USE PROCESSING COMPLETE

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

Nov 30, 2020

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

USE AMENDMENT FILED

Nov 24, 2020

USE AMENDMENT FILED

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

Nov 24, 2020

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

TEAS AMENDMENT OF USE RECEIVED

Nov 24, 2020

TEAS AMENDMENT OF USE RECEIVED

TEAS VOLUNTARY AMENDMENT RECEIVED

Nov 24, 2020

TEAS VOLUNTARY AMENDMENT RECEIVED

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 14, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 13, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 13, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

May 13, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 13, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 13, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 30, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 30, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Apr 27, 2020

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 23, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

Oct 24, 2019

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 24, 2019

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 24, 2019

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Oct 21, 2019

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 27, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Aug 14, 2019

NEW APPLICATION ENTERED

Other Marks by PathogenDx, Inc

Additional USPTO filings from the same owner.

LOG

LogoMark

88545657

PathogenDx, Inc

REGISTERED

SET

SETTING THE STANDARD IN DNA TESTING

88551195

PathogenDx, Inc

REGISTERED

QUA

QUANT X

88543648

PathogenDx, Inc

PENDING

ENV

ENVIRO X

88543675

PathogenDx, Inc

PENDING

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

PAT

PATHOGENDX

86789081

Pathogen Dx LLC

ABANDONED

Other Marks by Dr. Benjamin ADLER

Additional USPTO filings handled by the same attorney of record.

SER

SEROX

97802398

REGISTERED

D3A

D3 ARRAY

97802494

REGISTERED

CAC

CACARI

98152944

REGISTERED

PUR

PURIFYOU

87677284

REGISTERED

PATHOGENDX

Run a conflict check

Other Marks by PathogenDx, Inc

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Dr. Benjamin ADLER

Get pre-filing clearance

Search 14M+ trademarks

Industries

USPTO Deadlines

Compare

Resources

Company